Which antibiotic wins for liver infection? new study compares ciprofloxacin and ceftriaxone
NCT ID NCT07552870
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two antibiotics—ciprofloxacin and ceftriaxone—given intravenously to 310 patients with liver cirrhosis who developed a serious infection called spontaneous bacterial peritonitis. The goal was to see which drug better controlled fever, abdominal pain, and infection markers after 48 hours. The trial has completed, and results may help guide treatment choices for this life-threatening condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ciprofloxacin and ceftriaxone (antibiotics given intravenously)
- What this could lead to
- If one antibiotic proves more effective, it could become the preferred treatment for this serious infection in cirrhosis patients, potentially reducing hospital deaths.
- What could go wrong
- This is a single-center study with a moderate number of participants. Results may not apply to all patients, and both antibiotics have known side effects like allergic reactions or antibiotic resistance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nishtar Hospital
Multan, Punjab Province, 60000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?